Renin-Angiotensin System Blockade after Acute Kidney Injury (AKI) and Risk of Recurrent AKI.
Chi-Yuan HsuKathleen D LiuJingrong YangDavid V GliddenThida C TanLeonid PravoverovSijie ZhengAlan S GoPublished in: Clinical journal of the American Society of Nephrology : CJASN (2019)
In this study of AKI survivors without heart failure, new use of ACE-I/ARB therapy was not independently associated with increased risk of recurrent hospitalized AKI.